🦠 Tuberculosis: How does the bacterium remove toxic metals to survive?

The tuberculosis bacillus survives inside immune cells by neutralizing toxic metals like zinc. A study published in EMBO Journal reveals a novel mechanism: the assembly of "effluxosomes," dynamic membrane platforms that gather several molecular pumps to expel various metals from the bacterium. These findings shed light on the bacillus's physiology and could inspire new treatments targeting these structures.

Membrane platforms to escape destruction

When the tuberculosis bacillus, Mycobacterium tuberculosis, infects an organism, it is quickly phagocytosed by macrophages, immune cells tasked with eliminating it. Among their defense strategies, these cells use toxic metals, such as zinc, copper, and possibly cadmium, to poison the pathogen. Yet, M. tuberculosis manages to resist these attacks thanks to a sophisticated molecular mechanism.

Scientists have identified three proteins, PacL1, PacL2, and PacL3, which play a central role in organizing the bacterial membrane. PacL1 acts as a veritable "metal shuttle": it can bind zinc, cadmium, and copper thanks to a specific motif located at its tip, thereby facilitating their transfer to specialized membrane pumps. PacL2 and PacL3, for their part, ensure the stabilization of these pumps and their clustering into functional groups, forming efficient expulsion platforms called effluxosomes.

A dynamic and hierarchical organization

In a study published in the journal EMBO Journal, scientists combined genetic, biochemical approaches and advanced microscopy techniques to characterize these structures.

Using super-resolution microscopy, particularly PALM and sptPALM methods, they were able to visualize in real-time the formation, distribution, and mobility of effluxosomes in the bacterial membrane.

These observations reveal a dynamic and hierarchical organization. Some PacL proteins form stable clusters anchored in the bacterium's membrane, while others are mobile: they move rapidly within the membrane to capture toxic metals and transport them to the pumps. This organization allows the bacterium to react quickly to variations in metal concentration, thereby optimizing its survival in a hostile environment.

A new therapeutic target in the face of resistance

The implications of this discovery are major for the fight against tuberculosis, a disease that remains a global scourge with 1.5 million deaths per year. Management is all the more complex as strains of M. tuberculosis resistant to conventional antibiotics are multiplying, necessitating long, costly, and often toxic treatments.

By targeting effluxosomes, it might be possible to weaken the bacterium's resistance to toxic metals, making it more vulnerable to immune defenses or existing antibiotics. "Understanding how M. tuberculosis hijacks toxic metals to survive gives us precise and innovative targets," emphasizes Pierre Dupuy, the study's first author. "By targeting effluxosomes, we could develop treatments that make the bacterium vulnerable, even when it is resistant to antibiotic treatments."